These findings highlight the critical role of HGF from CAFs in mediating chemoresistance in A549 lung cancer cells through the Met/PI3K/AKT pathway, suggesting that targeting this axis could enhance the efficacy of paclitaxel therapy. Here, AKT1 is linked to lung cancer.